At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

Stylus Medicine, a startup founded by Patrick Hsu, has raised $85 million to develop a suite of technologies that it believes ...

TAHITI couples CRISPR with transposable elements from plants to edit cash crops such as corn and soybean with reduced ...

Yesterday, the US Court of Appeals for the Federal Circuit said scientists Jennifer Doudna and Emmanuelle Charpentier will ...

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR ...

The researchers have conducted a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique aimed at ...

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...

The Patent Trial and Appeal Board was ordered to review a claim by a UC Berkeley team that gene-editing technology originated in their studies and not with the Broad Institute of Harvard and MIT. Also ...

CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...

The country's third most valuable company by market cap is a study in contrasts. It's a wealth-altering 13-bagger over the ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...